India Glycols Demerger Creates Three Entities Amid Strong Specialty Chemicals Margin Expansion
India Glycols Ltd 路 Investor Presentation 路 03 Sept 2026, 3:01 am
India Glycols Demerger Creates Three Entities Amid Strong Specialty Chemicals Margin Expansion India Glycols Limited executed a strategic demerger effective 1st Sep'26, creating three independent listed entities: IGL Spirits (67% FY26 net revenue share), retained IGL (28%), and Ennature Biopharma (6%). The retained IGL business, focused on bio-based specialty chemicals, reported FY26 net sales of INR 1,164 Cr. Despite revenue moderation, adjusted EBITDA reached INR 330 Cr, driving a robust margin expansion to 28.4%. Looking ahead, management targets INR 2,000 Cr net revenue and INR 400 Cr EBITDA over the next 4-5 years, driven by specialty-led portfolio development.
Original exchange filing (PDF)
More announcements from India Glycols Ltd
- Please find attached. 路 17 Nov 2026
- Please find atached. 路 13 Nov 2026
- India Glycols Limited has informed the Exchange about General Updates 路 13 Nov 2026
- Please find attached. 路 13 Nov 2026
- India Glycols Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 13 Nov 2026
- Please refer to attachment. 路 13 Nov 2026
- Please find attached 路 18 Nov 2026
- Please find attached 路 18 Nov 2026
